Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (alpha-tocopherol) has been studied for its potential role in supporting or treating eczema (atopic dermatitis), primarily because of its antioxidant and anti-inflammatory properties. The rationale is that oxidative stress and inflammation are believed to contribute to the pathogenesis of eczema, and Vitamin E, as a fat-soluble antioxidant, may help mitigate these factors. Several small clinical studies and randomized controlled trials have explored both oral and topical Vitamin E in individuals with eczema. Some have shown a modest improvement in symptoms such as itching, erythema, and lesion severity, while others have found no significant benefit compared to placebo. A systematic review of the literature suggests that the evidence is limited and of low quality, often due to small sample sizes, short durations, and methodological issues. Overall, there is some scientific basis for the use of Vitamin E in eczema, but the evidence is not robust or conclusive. Therefore, Vitamin E should not be considered a primary treatment, and more extensive, high-quality studies are needed to establish its efficacy and safety for this condition. Clinical guidelines do not currently recommend Vitamin E as a standard therapy for eczema, but it may be used as an adjunct in certain cases under medical supervision.

More about Vitamin E (alpha-tocopherol)
More about Eczema

Other ingredients used for Eczema

Other health conditions supported by Vitamin E (alpha-tocopherol)

Products containing Vitamin E (alpha-tocopherol)